Securities

Latest Stories

Schumer Wants to Ban Lawmakers, Officials on Prediction Markets

Senate Democratic leader Chuck Schumer called on the House of Representatives and the White House to follow the Senate’s lead by imposing a ban on trading in fast-growing prediction markets.

By María Paula Mijares Torres

Berkshire Hathaway’s Cash Surges in Abel’s First Quarter as CEO

Berkshire Hathaway Inc.’s cash pile soared to its highest level ever and operating earnings jumped in Greg Abel’s first quarter as chief executive officer.

Corporate America Earnings Beat Back Wall Street’s Wall of Worry

First-quarter earnings season is delivering Wall Street better-than-expected results, propelling US equities’ run from one record to the next.

‘Golden’ or ‘Garbage’: Milken Signals New Private Credit Era

Months before Jamie Dimon’s infamous remark about more than one “cockroach” lurking in credit markets, TCW Group Inc. Chief Executive Officer Katie Koch warned the direct lending industry was due for a reckoning.

Coinbase Says Deal Reached on Key Part of Crypto Market Bill

Coinbase Global Inc. said a deal has been reached on a key stablecoin yield provision, potentially clearing a path for sweeping crypto legislation to move forward in the US Senate.

DMC Investors Drop Suit Against Leaders Over Decking Unit Sales

DMC Global Inc. investors have dropped their lawsuit alleging the manufacturing company’s board and top executives caused a $142 million goodwill impairment charge tied to weak decking and railing sales.

Northwest Bio Settles With Canaccord in Stock Manipulation Suit

Northwest Biotherapeutics Inc. and Canaccord Genuity LLC are seeking to settle claims the brokerage firm placed false stock sale orders to depress Northwest’s stock price, according to a federal court filing.

Novo-Backed Hemab Soars 89% After Upsized $301.5 Million IPO

Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company, surged 89% on Friday after raising $301.5 million in an upsized US initial public offering that priced at the top of a marketed range.

SEC Semiannual Reporting Proposal Clears White House Review

A Securities and Exchange Commission plan to let public companies cut quarterly disclosures to twice a year moved closer to reality after passing a White House review.

Twist Bioscience Agrees to $17.1 Million Investor Settlement

Twist Bioscience Corp. and two executives reached a nearly $17.1 million settlement to resolve allegations they misled investors about the company’s synthetic DNA quality and automated manufacturing.